Epix, GlaxoSmithKline deal

EPIX partnered with GSK to discover, develop and commercialize drug candidates targeting four G-protein coupled receptors (GPCRs) for a

Read the full 195 word article

How to gain access

Continue reading with a
two-week free trial.